Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom... see more

CSE:PMED - Post Discussion

Predictmedix AI Inc > Projected Revenues : $ 99,000,000 year one (1)
View:
Post by Hiddensecrets on Jul 16, 2020 8:49pm

Projected Revenues : $ 99,000,000 year one (1)

I expect that Predictmedix will be able to sign 10% of the Fortune 500 companies over the next year. 

That means 50 companies, each with approximately 55,000 employees.

I am assuming $ 3 fee per employee per month.

Revenue will be as follows:

50 companies * 55,000 employees * $ 3 per month * 12 months = $ 99,000,000/year


This goes directly to the bottom line as there is not much cost to PMED.

Given that we are in tech industry and more precisely in software, we will trade at about 7 times to 10 times sales. 

For year 1, calculation would bring us to stock price of $ 7 to $ 10 per share.

Remember that this is recurring, so year 2, we add another 50 Fortune 500 companies.

You get the drift.

HUGE OPPORTUNITY, tremendous GROWTH.

MPO
Comment by HornetHaabu on Jul 16, 2020 10:29pm
This is a very interesting piece. Whereas I once was trying to figure out how their revenue model was going to work, you seemingly have cracked the code. Would you personally pay $3 a month to pay a universal get safe entry screener? YES!!! consider installed at arenas.. 20000 attendance, $5 a scan. A SCAN.. each game. 82 or 180 games.. times x arenas .. annually .. daaaaym . Could be more cus we ...more  
Comment by ronrydell on Jul 17, 2020 10:35am
Never have seen so much pumping in my life regarding this company..PMED....also so much day trading and huge volume...usually a big jump at the open and then back off after three hours....but...this is a real company.....but I don't expect two dollars a share for a longer period of time. An enthusiastic support of this great company!
Comment by Higherhopes2020 on Jul 17, 2020 11:08am
Yes You are right. I am also An enthusiastic support of this great company!  All it takes is one Fortune 500 company contract.  Also toronto star Article: on June 22nd Toronto Star article about what Lester B Pearson Airport is doing: Your temperature will have to be checked, and soon this will be done at a dedicated portal that’s about a month away from being approved by ...more  
Comment by Gordie444 on Jul 17, 2020 4:11pm
We've been seeing green for over a week now. I think we will hit 2$ by mid August.
Comment by ronrydell on Jul 17, 2020 4:53pm
Pretty aggressive on that timeline....but would love it.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities